NXTC

Nextcure

12.77

+0.45+3.65%

After Hours: 12.77 0.00 0.00%16:59 04/14 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.30/12.32

TODAY RANGE12.08-13.50

VOL53.22K

MARKET CAP45.47M

52 WEEK RANGE3.493-15.74

AVG VOL (3M)38.31K

% TURNOVER1.49%

TURNOVER--

P/E (TTM)-0.6500

% RANGE11.53%

EPS(TTM)-19.6464

P/E(FORWARD)-1.5707

P/B1.281

BVPS9.97

DIVIDEND--

P/S1.956

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP38.57M

SHARES OUTSTANDING3.56M

NEXT EARNINGS04/29-05/04

FREE FLOAT3.02M

LOT SIZE1

EX-DATE07/14/2025

News

Press Releases

Financial Reports

Profile

TipRanks·04/07 14:31
NextCure granted Fast Track Designation for SIM0505 by FDA
Reuters·04/07 12:35
NextCure wins FDA Fast Track for SIM0505 in platinum-resistant ovarian cancer
Reuters·04/07 12:05
NEXTCURE RECEIVES FAST TRACK DESIGNATION FOR SIM0505 (CDH6 ADC) IN OVARIAN CANCER
Reuters·03/31 20:08
NextCure, Simcere CDH6 ADC abstract accepted for ASCO meeting
Seeking Alpha·03/06 07:47
NextCure GAAP EPS of -$19.65
Reuters·03/05 21:18
NextCure Publishes Corporate Presentation on Targeted ADC Cancer Therapies
Reuters·03/05 21:17
NextCure reports marginal increase in 2025 net loss
Dow Jones·03/05 21:12
*NextCure 2025 Loss/Shr $19.65 >NXTC
Dow Jones·03/05 21:11
*NextCure Sees Funding Oper Expenses and Cap Expenditures Into 1H of 2027 Through Proof-Of-Concept for SIM0505 >NXTC
Dow Jones·03/05 21:11
*NextCure Expects Current Fincl Resources to Sufficient to Fund Oper Expenses and Cap Expenditures Into 1H of 2027
Dow Jones·03/05 21:10
*NextCure: LNCB74 Phase 1 Dose Escalation Trial Update Planned in 2H of 2026 >NXTC
TipRanks·03/02 14:55
NextCure trading resumes
Reuters·01/26 06:55
NextCure Advances SIM0505 and LNCB74 ADCs in Phase 1 Cancer Trials
TipRanks·01/23 12:47
NextCure Updates ADC Pipeline Progress and Cash Runway
Reuters·01/23 12:11
NextCure Inc. Highlights Targeted Cancer Therapy and Clinical Pipeline in New Presentation

Same Industry

Name/Symbol

Change%

Price

NXTC

REGN

GRDX

BNTX

UTHR

VRTX

Siga Technologie

SIGA

+2.29%

4.460

Moderna

MRNA

-0.62%

50.96

CRL

MEDP

Talphera Inc

TLPH

-6.35%

0.7606

ICLR

CBPO

Iqvia Hldgs Inc

IQV

-0.97%

167.34

MOLN

ARCT

Gilead Sciences Inc

GILD

-2.18%

138.99

PRAH

INCY

APVO

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.